Wednesday, August 15, 2018
Company News: Page (1) of 1 - 08/10/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Fusionetics Closes Capital Investment from Stella
Musculoskeletal performance system set to expand national reach through strategic relationship with national health solutions company
(August 10, 2018)

MILTON, Ga. and EAGAN, Minn., Aug. 10, 2018 /PRNewswire/ -- Fusionetics, a leader in sports medicine and musculoskeletal performance health care, announced a capital investment by Stella Development, a division of the same parent company (Stella) as Blue Cross and Blue Shield of Minnesota. Fusionetics will use the capital primarily to fuel growth of its Fusionetics system in the health care sector.

Fusionetics is a performance health system that is revolutionizing how technology can intersect with health care. By turning complex science into simple, efficient and results-oriented applications accessible through a computer or personal digital device, Fusionetics is designed to reduce injuries, decrease pain, optimize performance and speed recovery.

The Stella investment and partnership significantly accelerates and expands Fusionetics' health care strategy. When paired with Stella's expertise in developing, deploying and scaling innovative capabilities within health care, Fusionetics' preventative solutions now have the potential to benefit self-insured employers, health plans, hospital systems and providers across the country. 

"Stella is the ideal strategic partner to bring our preventative, individualized and non-invasive solutions to millions of people," said Dr. Mike Clark, founder and CEO of Fusionetics. "The entire Fusionetics leadership team is energized by this great opportunity to work with Stella and collaborate on new approaches to help even more individuals lower their risk for long-term musculoskeletal disorders."

 "At Stella, our strategy is driven in large part by our desire to combine innovative solutions with an ability to make a tangible impact on those we serve," said Mike Zeman, vice president and chief growth officer at Stella. "This investment underscores our belief in how Fusionetics can advance the kind of health and economic value that our customers are searching for in the market."

Fusionetics has previously partnered with major hospital systems, including Baylor Scott & White Health. Fusionetics powers the Sports Performance Center of Baylor Scott & White's Sports Therapy & Research Center at the Star – a one-of-a-kind partnership between a hospital system, professional sports team and independent school district to create the premier sports medicine and performance healthcare facility in the world.    

About Fusionetics
Fusionetics has created and licenses an evidence-based, technology-enabled digital sports medicine and musculoskeletal performance healthcare system.  The Fusionetics® System has been trusted by hundreds of professional and collegiate sports teams and thousands of athletes for over 25 years to prevent injury and reduce pain, enhance performance, accelerate recovery and minimize the cost of injury.  Today, over 500 professional and collegiate teams and leading hospital systems utilize the Fusionetics® System.  Fusionetics' key markets include health care, sports and fitness organizations with at-risk populations of employees, insured lives, professional collegiate and youth athletes, and fitness enthusiasts.  Our mission is to help every "body" move better, perform stronger, recover faster and minimize the risk and cost of injury.

About Stella
Stella is a Minnesota-based company designed to nurture and scale differentiated businesses across the country to improve health in bold and innovative ways. Stella serves as the parent company for a number of entities that share a focus of making a healthy difference in people's lives, including the non-profit health insurer Blue Cross and Blue Shield of Minnesota and its subsidiaries, and diversified affiliate companies including Further and ClearStone Solutions, Inc. Go to to learn more.





Cision View original content with multimedia:


Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords: Inc.,Science,Sports,Medical,Science,Sports,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • New Report Identifies Unique Challenges for LGBT Community Facing Alzheimer's and Other Dementias
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease,
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease
  • Global Spinal Fusion Devices Market Expected to Reach USD 6.8 Billion By 2024: Zion Market Research

  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • ViewRay Announces Pricing of Public Offering of Common Stock
  • Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2012-2018: Deal trends, players, financials and forecasts
  • CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results
  • Citius Announces Closing of $10.0 Million Underwritten Offering Priced At-the-Market

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines